Figure 3
Figure 3. Activation of endosomal iPLA2 activity by ROSs. Endosomal vesicles were purified from reticulocytes and used to measure iPLA2 activity with the bodipy FL11 PC probe as described in “Measurement of iPLA2 activity in endosomes.” (A) The enzymatic activity was measured in the absence (CTRL) or presence of the iPLA2-specific inhibitor bromoenolactone (BEL; 100μM). (B) Endosomal vesicles were incubated with H2O2 (3% and 15%) for 30 minutes before measuring iPLA2 activity. In some cases, vesicles were treated with BEL, as described in panel A, prior to H2O2 activation. Data are presented as means (± SD) of triplicate samples.

Activation of endosomal iPLA2 activity by ROSs. Endosomal vesicles were purified from reticulocytes and used to measure iPLA2 activity with the bodipy FL11 PC probe as described in “Measurement of iPLA2 activity in endosomes.” (A) The enzymatic activity was measured in the absence (CTRL) or presence of the iPLA2-specific inhibitor bromoenolactone (BEL; 100μM). (B) Endosomal vesicles were incubated with H2O2 (3% and 15%) for 30 minutes before measuring iPLA2 activity. In some cases, vesicles were treated with BEL, as described in panel A, prior to H2O2 activation. Data are presented as means (± SD) of triplicate samples.

Close Modal

or Create an Account

Close Modal
Close Modal